Speaker
William Mann, PhD
PRESIDENT & CEO, ARCHIMMUNE THERAPEUTICS, INC.
Lexington, Massachusetts, United States
William joined Archimmune in November 2022 as President & CEO. Previously, he was President & COO of NeuBase Therapeutics, Inc. (Nasdaq: NBSE), President & CEO of Helsinn Therapeutics U.S., and VP of corporate development at Sapphire Therapeutics.
Speaking In
9:30 AM - 9:45 AM (EST)
Tuesday, February 7
Archimmune is an immuno-oncology platform company. Its first program is aimed at developing…
Palace